Blend

KLOW Blend

Peptide Blend

Also referred to as KLOW.

KLOW Blend is a research formulation combining four bioactive peptides — GHK-Cu, BPC-157, TB-500, and KPV (lysine-proline-valine) — each with its own preclinical and, in some cases, clinical research record. No published studies have examined this four-component combination itself; findings from individual component research cannot be assumed to transfer to the blend without direct evidence.

The published literature for the individual components is predominantly preclinical. Human data exists for BPC-157 in small observational contexts and for GHK-Cu in skin applications, but no randomised controlled trials have been published for any component. The most fundamental gap is the absence of any study on the blend as a combination.

Published on KLOW Blend

Research OverviewKLOW Blend Peptide: What Is It Studied For?KLOW Blend peptide is a research formulation combining four bioactive peptides — GHK-Cu (glycyl-L-histidyl-L-lysine copper complex), BPC-157 (body protection compound 157), TB-500 (a Thymosin β4-derived fragment), and KPV (lysine-proline-valine) — each with its own preclinical and, in some cases, clinical research record.